Genomic Services

ABOUT XING Genomic Services

XING Genomic Services is an Australian company providing an extensive range of molecular biology laboratory services to support preclinical/clinical trial studies, including full customized assay validation in specialized areas of clinical cancer sequencing and biodistribution studies.

Our laboratory services are performed under National Association of Testing Authorities, Australia (NATA) AS ISO 15189-certified. This ensures our quality management systems and competence assessment of our molecular biology team are held to a worldwide-recognized standard, therefore providing our clients trust in the quality of our services.

Next Generation Sequencing (NGS) for
Homologous Recombination deficiency (HRD)

Biodistribution/Excretion Testing

  • The EMBRACE Study: Phase II clinical trial of the PARP inhibitor, Olaparib, in HR-deficient metastatic breast and relapsed ovarian cancer
  • NGS testing for SNP/Indels, copy number, and promoter methylation

“XING has been a fantastic partner to work with on the Embrace trial. They have provided a smooth process for screening, from test request to final reports. I would recommend XING without reservation for future clinical
trials.”
Katrin Sjoquist, MBBS MClinT(R) FRACP (Principal Investigator & Medical Oncologist), EMBRACE Phase II Clinical Trial

  • A placebo-controlled, non-clinical toxicity mouse study entailing administration of an adenovirus vector-based test item
  • Sample extraction and qPCR assays to quantify the adenovirus vector DNA in tissue, stool and urine are developed and validated

“I really appreciate XING’s prompt and effective communication throughout to ensure our study objectives are met. They delivered testing data of excellent quality and integrity to provide us trust in their services. I would highly recommend XING for the quality service they provide and would be happy to partner with them again for future studies.”
Russell Rother, Ph.D. (President and COO), Tetherex
Pharmaceuticals Corporation

Located in Brisbane, our business is highly client oriented to ensure our clients receive top value laboratory services by partnering with us. We strive to work closely with our clients with prompt and timely communications to achieve quality deliverables that successfully meet client expectations. Our services include precision oncology (eg. epigenomics) profiling or pharmacokinetic (eg. biodistribution, excretion) testing of antibodies, protein therapeutics, viral vectors etc.

Sample Processing

DNA/RNA Analysis

Customized Assay Qualification / Validation

Immunoassay Bioanalysis

Service Support

  • DNA/RNA/protein extraction from a diverse range of sample matrices such as solid tissues, cultured cells, swabs, stools and various biofluids (eg. blood, urine, wastewater)

  • Extracted DNA/RNA quantification, quality assessment, an fragment size analysis

  • Biomarker level quantification via real-time PCR
  • DNA/RNA sequencing
  • Gene expression assessment
  • Copy number variation
  • Genotyping
  • Primer/probe design using in-house bioinformatics pipeline
  • Sourcing of commercially available assay kits and fit-for-purpose verification
  • Primer/probe testing and optimization for DNA/RNA biotargets
  • Stringent assay design, validation and transfer workflow
  • Stringent assay design, validation and transfer workflow
  • Western blot
  • SDS-PAGE
  • Sourcing of commercially available antibodies and fit-for-purpose immunoassay verification
  • Experienced team with a proven track record in scientific technical proficiencies and project management
  • Rapid generation of laboratory service scope and budget for consideration
  • Prompt and responsive communication
  • Punctual delivery of service deliverables within budget
  • Quality compliant data integrity and service reports

NATA ISO 15189 Accredited

XING Cancer Care

XING Genomics Services delivers array-based and customised massively parallel sequencing solutions to clients in industry and academia using the iScan, NextSeq550, and NovaSeq platforms.

XING Group Holdings has a clear vision in applying point-of-care diagnostic nanotechnologies to globally enhance healthcare systems. XING's service and product lines currently span from cancer care to rapid nucleic acid extraction, protein detection diagnostics, and nanoparticle capture agents to identify and prevent the spread of infectious diseases.

NATA ISO 15189 accredited

XING Genomics Services delivers array-based and customised massively parallel sequencing solutions to clients in industry and academia using the iScan, NextSeq550, and NovaSeq platforms.

Scroll to Top